Experts: Telemedicine can bridge mental health gap
Modern technology offers a way to deliver much-needed mental health care to rural sections of Indiana where little or none is available, experts told a legislative study committee Thursday.
Health Care & Life Sciences
Articles
The Interview Issue: Ron Ellis
Ron Ellis has been CEO of the drug discovery firm Endocyte Inc. since 1996. When he moved to West Lafayette to take the job, he wouldn’t let his wife paint the interior of their new house—for fear he’d be looking for a new job soon. Endocyte has yet to generate any revenue.
The pain (and pleasure) that comes from paying more of our health care bills
Paying off medical debts over time is now a common experience for families with health insurance and becoming more so. And that is inducing big changes in the health care marketplace.
Advocates seek action on Indiana Medicaid plan
Health care advocates and industry lobbyists are asking federal officials for speedy approval of Indiana's request for a Medicaid expansion.
Rise in bed sores pushes state medical errors to new high
Overall, 111 medical errors were reported in 2013, the biggest number in any year since the state began reporting them in 2006.
Major Health to put new $89 million hospital along I-74
Major Health Partners will construct the new hospital on the north edge of Shelbyville, after nearly a decade of shifting services to that location. Construction could begin next month.
LDI acquisition could be latest springboard for growth
Indianapolis-based private investment company LDI Ltd. has acquired a small biotech manufacturer in a deal it says could be the launching point for many more acquisitions.
IU Health to bypass Indy next year on Obamacare exchange
IU Health Plans, the insurance arm of the Indianapolis-based hospital system, is limiting itself to three middle-size markets next year—Bloomington, Lafayette and Muncie—even though the bulk of its facilities is in the metro area.
Why small firms have been irate about health insurance
For Indiana employers with fewer than 10 workers, health insurance premiums have risen 11.5 percent, on average, from 2001 to 2013. That ranked second-highest among all states.
Obamacare enrollment at 7.3 million people, official says
That’s a 9-percent reduction from the government’s May estimate of 8 million, which reflected only how many people had signed up, not how many had paid and were enrolled in the coverage.
FDA approves Eli Lilly’s injectable diabetes drug
The agency on Thursday cleared the drug, Trulicity, as a weekly injection to improve blood sugar control in patients with type 2 diabetes, which affects more than 26 million Americans.
What if hospitals ‘upcharged’ you for being fat?
As local hospitals try to offer package deals with upfront prices on joint replacement surgeries, they're struggling with the reality that patients' other health conditions can significantly increase their cost of care.
Testosterone drugs need study on heart risks, FDA panel says
Drugmakers, including Eli Lilly and Co., should conduct new trials to assess the heart risks of testosterone therapies used by millions of men last year, advisers to U.S. regulators said.
Abortion-related complaints filed against doctors
Attorney General Greg Zoeller's office filed licensing complaints Wednesday against an Illinois doctor facing misdemeanor charges in Indiana and against three physicians who perform abortions in Indianapolis.
Community Health plans $175M expansion of East facilities
Community executives said the investment and projects, which will begin this fall and extend over several years, prove their long-term commitment to the east side of the city.
FDA set to review testosterone-boosting drug usage
Testosterone supplements used last year by about 2.3 million men are spurring debates over how necessary and safe they may be, even as U.S. regulators consider approving a new product.
Lilly to pay AstraZeneca up to $500M in Alzheimer’s push
The two companies will work together to develop AZD3293, which belongs to a novel class of drugs called BACE inhibitors that block production of amyloid, a protein that causes plaque to build up in the brain of Alzheimer’s patients.
Sheriffs: Mentally ill people swamping Indiana jails
County jails have become the "insane asylum" for Indiana as state hospital care for the mentally ill has declined, a sheriff told a legislative committee in Indianapolis on Monday.
Obamacare exchanges boosted coverage, premiums and spending in Indiana
A new study finds that Obamacare boosted enrollment in Indiana’s individual insurance market significantly over what it would have been without the law, but also caused premiums to spike.
Recent wins worth $4B to Lilly market value
Lilly is finally putting meat on the bones of its predictions about its experimental diabetes and cancer drugs. That gives investors the certainty they crave that Lilly’s future revenue won’t remain in its 2014 doldrums.